My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format

Send to:

Choose Destination

    J Clin Invest. 2002 Jul;110(2):141-4.

    Development of an improved vaccine for anthrax.

    Leppla SH, Robbins JB, Schneerson R, Shiloach J.

    National Institute of Dental and Craniofacial Research, NIH, Bethesda, Maryland 20892-4350, USA. Leppla@nih.gov

    PMID: 12122102 [PubMed - indexed for MEDLINE]

    PMCID: PMC151073

    Publication Types, MeSH Terms, Substances

    Publication Types:

    MeSH Terms:

    Substances:

    LinkOut - more resources

    Full Text Sources:

    Medical:

    Libraries:

    Supplemental Content

    Click here to read Click here to read

    Related articles

    Cited by 25 PubMed Central articles

    Patient drug information

    • Anthrax Vaccine (Biothrax®)

      Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria calledBacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides. In its most common...

    • Source: AHFS Consumer Medication Information

    All links from this record

    • Related Articles

      Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.

    • References for this PMC Article

      Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.

    • Substance (MeSH Keyword)

      PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

    • Free in PMC

      Free full text articles in PMC

    • Cited in PMC

      Full-text articles in the PubMed Central Database that cite the current articles.

    Recent activity